Ephedra sinica inhibits complement activation and improves the motor functions after spinal cord injury in rats

Brain Research Bulletin

Volumn 78, Issue 4-5, 2009, Pages 261-266

  Li, Liangman ^a   Li, Jingbo ^a   Zhu, Yue ^a   Fan, Guangyu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Complement; Ephedra sinica; Inflammation; Spinal cord injury

Indexed keywords

EPHEDRA SINICA EXTRACT; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EPHEDRA SINICA; MOTOR PERFORMANCE; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; SPRAGUE DAWLEY RAT;

ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT C9; COMPLEMENT HEMOLYTIC ACTIVITY ASSAY; DISEASE MODELS, ANIMAL; EPHEDRA SINICA; IMMUNOHISTOCHEMISTRY; MOTOR ACTIVITY; PEROXIDASE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD INJURIES;

EID: 58749097944     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2008.10.002     Document Type: Article

References (36)

1. Anderson A.J., Robert S., Huang W., Young W., and Cotman C.W. Activation of complement pathways after contusion-induced spinal cord injury. J. Neurotrauma 21 (2004) 1831-1846
2. Arumugam T.V., Magnus T., Woodruff T.M., Proctor L.M., Shiels I.A., and Taylor S.M. Complement mediators in ischemia-reperfusion injury. Clin. Chim. Acta 374 (2006) 33-45
3. Asghar S.S., and Pasch M.C. Therapeutic inhibition of the complement system. Y2K update. Front Biosci. 5 (2000) 63-81
4. Bao F., Chen Y., Dekaban G.A., and Weaver L.C. Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats. J. Neurochem. 88 (2004) 1335-1344
5. Basso D.M., Beattie M.S., Bresnahan J.C., Anderson D.K., Faden A.I., Gruner J.A., et al. MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Neurotrauma 13 (1996) 343-359
6. Berger H.J., Taratuska A., Smith T.W., and Halperin J.A. Activated complement directly modifies the performance of isolated heart muscle cells from guinea pig and rat. Am. J. Physiol. 265 (1993) 267-272
7. Beril G.H., Solaroglu I., Okutan O., Cimen B., Kaptanoglu E., and Palaoglu S. Metoprolol treatment decreases tissue myeloperoxidase activity after spinal cord injury in rats. J. Clin. Neurosci. 14 (2007) 138-142
8. Costa C., Zhao L., Shen Y., Su X., Hao L., Colgan S.P., Stahl G.L., Zhou T., and Wang Y. Role of complement component C5 in cerebral ischemia/reperfusion injury. Brain Res. 1100 (2006) 142-151
9. Dyer J.K., Bourque J.A., and Steeves J.D. The role of complement in immunological demyelination of the mammalian spinal cord. Spinal Cord 43 (2005) 417-425
10. Fitch M.T., and Silver J. CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp. Neurol. 209 (2008) 294-301
11. Fleming J.C., Norenberg M.D., Ramsay D.A., Dekaban G.A., Marcillo A.E., Saenz A.D., Pasquale-Styles M., Dietrich W.D., and Weaver L.C. The cellular inflammatory response in human spinal cords after injury. Brain 129 (2006) 3249-3269
12. Gonzalez R., Glaser J., Liu M.T., Lane T.E., and Keirstead H.S. Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury. Exp. Neurol. 184 (2003) 456-463
13. Harrison R.A., and Lachman P.J. Complement technology. In: Wier D.M. (Ed). Handbook of Experimental Immunology Immunochemistry vol. 1 (1986), Blackwell Scientific Publications, Oxford
14. Kulkarni A.P., Kellaway L.A., and Kotwal G.J. Herbal complement inhibitors in the treatment of neuroinflammation: future strategy for neuroprotection. Ann. N. Y. Acad. Sci. 1056 (2005) 413-429
15. Kwon B.K., Tetzlaff W., Grauer J.N., Beiner J., and Vaccaro A.R. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J. 4 (2004) 451-464
16. Lee B.H., Lee K.H., Kim U.J., Yoon D.H., Sohn J.H., Choi S.S., Yi I.G., and Park Y.G. Injury in the spinal cord may produce cell death in the brain. Brain Res. 1020 (2004) 37-44
17. Li L.M., Zhu Y., and Fan G.Y. Effects of recombinant sCR1 on the immune inflammatory reaction in acute spinal cord injury tissue of rats. Chin. J. Traumatol. 8 (2005) 49-53
18. Ling M., Piddlesden S.J., and Morgan B.P. A component of the medicinal herb ephedra blocks activation in the classical and alternative pathways of complement. Clin. Exp. Immunol. 102 (1995) 582-588
19. Liu Y., Luo J., and He F. Experimental study on anti-inflammatory effects of mahuang decoction and its compositions. Zhong Yao Cai 28 (2005) 413-415
20. Mollnes T.E., Jokiranta T.S., Truedsson L., Nilsson B., Rodriguez de Cordoba S., and Kirschfink M. Complement analysis in the 21st century. Mol. Immunol. 44 (2007) 3838-3849
21. Morgan B.P. Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem. J. 264 (1989) 1-14
22. Nessler J.A., De Leon R.D., Sharp K., Kwak E., Minakata K., and Reinkensmeyer D.J. Robotic gait analysis of bipedal treadmill stepping by spinal contused rats characterization of intrinsic recovery and comparison with BBB. J. Neurotrauma 23 (2006) 882-896
23. Nicolson-Weller A., and Happerin J.A. Membrane signaling by complement C5b-9, the membrane attack complex. Immunol. Res. 12 (1993) 244-257
24. Okano H., Kaneko S., Okada S., Iwanami A., Nakamura M., and Toyama Y. Regeneration-based therapies for spinal cord injuries. Neurochem. Int. 51 (2007) 68-73
25. Qiao F., Atkinson C., Song H., Pannu R., Singh I., and Tomlinson S. Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma. Am. J. Pathol. 169 (2006) 1039-1047
26. Rabchevsky A.G., Fugaccia I., Fletcher-Turner A., Blades D.A., Mattson M.P., and Scheff S.W. Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury. J. Neurotrauma 16 (1999) 817-830
27. Ray S., Phadke S., Patel C., Hackman R.M., and Stohs S. Short-term and long-term in vivo exposure to an ephedra- and caffeine-containing metabolic nutrition system does not induce cardiotoxicity in B6C3F1 mice. Arch. Toxicol. 79 (2005) 330-340
28. Reynolds D.N., Smith S.A., Zhang Y.P., Mengsheng Q., Lahiri D.K., Morassutti D.J., Shields C.B., and Kotwal G.J. Vaccinia virus complement control protein reduces inflammation and improves spinal cord integrity following spinal cord injury. Ann. N. Y. Acad. Sci. 1035 (2004) 165-178
29. Rossignol S., Schwab M., Schwartz M., and Fehlings M.G. Spinal cord injury: time to move?. J. Neurosci. 27 (2007) 11782-11792
30. Schwab J.M., Brechtel K., Mueller C.A., Failli V., Kaps H.P., Tuli S.K., and Schluesener H.J. Experimental strategies to promote spinal cord regeneration-an integrative perspective. Prog. Neurobiol. 78 (2006) 91-116
31. Shen A., Liu Y., Zhao J., Qin J., Shi S., Chen M., Gao S., Xiao F., Lu Q., and Cheng C. Temporal-spatial expressions of p27kip1 and its phosphorylation on Serine-10 after acute spinal cord injury in adult rat: implications for post-traumatic glial proliferation. Neurochem. Int. 52 (2008) 1266-1275
32. Swarup V., Ghosh J., Das S., and Basu A. Tumor necrosis factor receptor-associated death domain mediated neuronal death contributes to the glial activation and subsequent neuroinflammation in Japanese encephalitis. Neurochem. Int. 52 (2008) 1310-1321
33. Taoka Y., Okajima K., Uchiba M., Murakami K., Kushimoto S., Johno M., Naruo M., Okabe H., and Takatsuki K. Role of neutrophils in spinal cord injury in the rat. Neuroscience 79 (1997) 1177-1182
34. Tei R., Kaido T., Nakase H., and Sakaki T. Protective effect of C1 esterase inhibitor on acute traumatic spinal cord injury in the rat. Neurol. Res. 30 (2008) 712-717
35. Trivedi A., Olivas A.D., and Noble-Haeusslein L.J. Inflammation and spinal cord injury: infiltrating leukocytes as determinants of injury and repair processes. Clin. Neurosci. Res. 6 (2006) 283-292
36. Yamada I., Goto T., Takeuchi S., Ohshima S., Yoneyama K., Shibuya T., Kataoka E., Segawa D., Sato W., Dohmen T., Anezaki Y., Ishii H., and Ohnishi H. Mao (Ephedra sinica Stapf) protects against d-galactosamine and lipopolysaccharide-induced hepatic failure. Cytokine 41 (2008) 293-301